EMA Commissions Research On Real-World Monitoring Of COVID-19 Vaccines
Experts Offer Guidance On Pharmacoepidemiological Analyses During Pandemic
Executive Summary
The European Medicines Agency is taking steps to establish infrastructure for monitoring COVID-19 vaccines whenever they reach the European market.
You may also be interested in...
EMA All Set To Oversee Use Of COVID-19 Treatments, Vaccines In Clinical Practice
The European Medicines Agency has finalized infrastructure to monitor the safety and effectiveness of COVID-19 medicines and vaccines when they are used in day-to-day clinical practice following marketing authorization.
EU Guide Supports Strong Observational Research For COVID‐19
An EU guideline on the methodological aspects of pharmacoepidemiology has been updated to promote collaboration by researchers on high-quality, multi-centre observational studies in the context of COVID-19.
New Consortium To Monitor Whether COVID-19 Vaccines Work As They Should
As the efficacy of most COVID-19 vaccines will likely be assessed using biomarkers and limited clinical data, monitoring their performance in the real-world is essential.